02:12 AM EDT, 05/06/2026 (MT Newswires) -- Novo Nordisk (NOVO-B.CO) said Wednesday its net profit and sales for the first quarter increased year over year.

Net profit for the three months ended March 31 was 48.56 billion Danish kroner, compared with 29.03 billion kroner a year earlier. EPS moved to 10.91 kroner from 6.53 kroner.

The Danish drugmaker's net sales were 96.82 billion kroner, compared with 78.09 billion kroner a year ago.

The company raised its 2026 outlook. It expects its adjusted sales to fall 4% to 12% at constant exchange rates, compared with the previous guidance of a 5% to 13% decline. Adjusted operating profit is now expected to fall 4% to 12%, compared to the previously guidance of a 5% to 13% drop.